QuickView for oligosaccharide-lipid intermediate biosynthetic process (biogroup)

1. OMIM - Congenital disorder
2. Calu-3 lung adenocarcinoma cells infected with wildtype and mutant SARS virus
3. Acute monocytic leukemia THP1 cells with CRISPR-CAS9 mediated HNRNPC and ADAR knockout
4. Breast epithelial MCF10A and MCF10A-ERBB2 cell lines with static or flowing interstitial fluid
5. Monocytes from peripheral blood cultured in RPMI media or uric acid with or without LPS

There were no matches for oligosaccharide-lipid intermediate biosynthetic process

There were no clinical trials for oligosaccharide-lipid intermediate biosynthetic process